Non-Hodgkin's Lymphoma

Showing NaN - NaN of 27

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Non-Hodgkin's Lymphoma Trial in United States (CG-806)

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Phoenix, Arizona
  • +30 more
Mar 28, 2022

Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Duarte, California
  • +16 more
Dec 3, 2021

Non-Hodgkin's Lymphoma Trial in United States (ABT-199, Rituximab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • La Jolla, California
  • +7 more
Jul 29, 2021

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

Completed
  • Non-Hodgkin's Lymphoma
    • Los Angeles, California
    • +3 more
    Nov 24, 2020

    Non-Hodgkin's Lymphoma Trial in Worldwide (ibritumomab tiuxetan, BEAM chemo and autologous stem-cell transplantation)

    Completed
    • Non-Hodgkin's Lymphoma
    • ibritumomab tiuxetan
    • BEAM chemotherapy and autologous stem-cell transplantation
    • Scottsdale, Arizona
    • +8 more
    Aug 13, 2020

    Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

    Completed
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Tucson, Arizona
    • +127 more
    Jan 8, 2018

    Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Canada, United States (CAT-8015 (Moxetumomab Pasudotox))

    Completed
    • Acute Lymphoblastic Leukemia
    • Non-Hodgkin's Lymphoma
    • CAT-8015 (Moxetumomab Pasudotox)
    • Los Angeles, California
    • +4 more
    Aug 28, 2017

    Non-Hodgkin's Lymphoma Trial in Los Angeles (Doxorubicin, Rituxan, Cyclophosphamide, Vincristine and Prednisone)

    Completed
    • Non-Hodgkin's Lymphoma
    • Doxorubicin, Rituxan, Cyclophosphamide, Vincristine and Prednisone
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center and Hospital
    Jul 13, 2017

    Non-Hodgkin's Lymphoma Trial in United States (AME-133v (LY2469298))

    Completed
    • Non-Hodgkin's Lymphoma
    • AME-133v (LY2469298)
    • Birmingham, Alabama
    • +10 more
    Jan 5, 2016

    Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease Trial in United States

    Completed
    • Lymphoblastic Leukemia, Acute, Childhood
    • +3 more
    • Los Angeles, California
    • +19 more
    Nov 20, 2015

    Hematologic Malignancies, Acute Myeloid Leukemia, Lymphoid Leukemia Trial in Worldwide (StemEx®)

    Completed
    • Hematologic Malignancies
    • +6 more
    • Los Angeles, California
    • +29 more
    Jul 9, 2015

    Non-Hodgkin's Lymphoma Trial in Worldwide (obinutuzumab (RO5072759), rituximab)

    Completed
    • Non-Hodgkin's Lymphoma
    • Los angeles, California
    • +70 more
    Aug 15, 2014

    Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Los Angeles (Noscapine)

    Terminated
    • Non-Hodgkin's Lymphoma
    • Chronic Lymphocytic Leukemia
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center and Hospital
    May 20, 2014

    Non-Hodgkin's Lymphoma, Burkitt Lymphoma, Primary Effusion Lymphomas Trial in Los Angeles (Pegylated Liposomal Doxorubicin

    Terminated
    • Non-Hodgkin's Lymphoma
    • +2 more
    • Pegylated Liposomal Doxorubicin (Doxil) and Rituximab
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center and Hospital
    May 20, 2014

    Non-Hodgkin's Lymphoma Trial in Los Angeles (Elsamitrusin)

    Completed
    • Non-Hodgkin's Lymphoma
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center
    May 20, 2014

    Non-Hodgkin's Lymphoma Trial in Australia, Canada, United States (bendamustine and rituximab)

    Completed
    • Non-Hodgkin's Lymphoma
    • bendamustine and rituximab
    • Anchorage, Alaska
    • +33 more
    May 8, 2014

    Non-Hodgkin's Lymphoma Trial in Canada, Puerto Rico, United States (Bendamustine HCl)

    Completed
    • Non-Hodgkin's Lymphoma
    • Bendamustine HCl
    • Birmingham, Alabama
    • +39 more
    May 8, 2014

    Non-Hodgkin's Lymphoma Trial in United States (IDEC-114)

    Completed
    • Non-Hodgkin's Lymphoma
    • Birmingham, Alabama
    • +21 more
    Sep 12, 2013

    Non-Hodgkin's Lymphoma Trial in Worldwide (Bortezomib + Rituximab, Rituximab)

    Completed
    • Non-Hodgkin's Lymphoma
    • Opelika,, Alabama
    • +205 more
    Jun 19, 2012

    Non-Hodgkin's Lymphoma Trial in Worldwide (rituximab)

    Completed
    • Non-Hodgkin's Lymphoma
    • Los Angeles, California
    • +45 more
    Oct 16, 2009

    Non-Hodgkin's Lymphoma Trial in United States (Id-KLH)

    Unknown status
    • Non-Hodgkin's Lymphoma
    • Id-KLH
    • La Jolla, California
    • +14 more
    Sep 29, 2009

    Non-Hodgkin's Lymphoma Trial in United States (autologous immunoglobulin idiotype-KLH conjugate vaccine)

    Terminated
    • Non-Hodgkin's Lymphoma
    • autologous immunoglobulin idiotype-KLH conjugate vaccine
    • Los Angeles, California
    • +8 more
    Mar 14, 2008